Figure 2: Novel Incretin Mimetic Assets for T2DM and Obesity in Phase 2/3 of Development Remaining Unmet Needs Remaining Unmet Needs Though the value proposition of on-market GLP-1 and dual-agonists is strong, several key unmet needs still exist for incretin mimetics across diabetes and obesity, namely: (1) improved efficacy, (2) better tolerability, (3) more convenient options / alternative ROAs, and (4) improved access and affordability
Providers must hold a California medical license
they have also recently been approved in other indications, such as cardiovascular disease prevention and sleep apnea
This means food stays in your stomach longer, keeping you feeling full for a more extended period
If double-priming occurs repeatedly, contact your PlexusDx provider to discuss whether dose-timing adjustments are needed
In fact, some legal experts suggest that simply prescribing BPC-157 is malpractice per se, since its impossible to adequately inform a patient of risks that havent been studied
